Kyung Dong Pharmaceutical Co. Ltd (011040) — Capital Reinvestment Ratio
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Capital Reinvestment Ratio of 0.32x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩5.70 Billion) in capital expenditures (₩1.84 Billion). See cash generation quality of Kyung Dong Pharmaceutical Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kyung Dong Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Kyung Dong Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. For live market cap and broader valuation context, see 011040 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.21x | ₩16.93 Billion | ₩20.51 Billion | ▲ +283.3% |
| 2021 | 0.32x | ₩12.42 Billion | ₩3.93 Billion | ▼ -81.1% |
| 2020 | 1.67x | ₩17.12 Billion | ₩28.59 Billion | ▲ +1313.5% |
| 2018 | 0.12x | ₩33.27 Billion | ₩3.93 Billion | ▼ -69.6% |
| 2017 | 0.39x | ₩14.79 Billion | ₩5.74 Billion | ▲ +38.3% |
| 2016 | 0.28x | ₩25.63 Billion | ₩7.19 Billion | ▼ -53.8% |
| 2015 | 0.61x | ₩18.26 Billion | ₩11.10 Billion | ▼ -34.8% |
| 2014 | 0.93x | ₩22.73 Billion | ₩21.17 Billion | ▲ +63.0% |
| 2013 | 0.57x | ₩16.42 Billion | ₩9.38 Billion | ▲ +61.4% |
| 2012 | 0.35x | ₩19.96 Billion | ₩7.06 Billion | ▲ +277.9% |
| 2011 | 0.09x | ₩26.08 Billion | ₩2.44 Billion | — |